News by Subject Business & Economics

Shift-work and irregular work schedules can cause several health-related issues and affect our defence against infection, according to new research from the University of Waterloo.

Augmented reality is an effective technology that marketers can use to improve sales.

An article published in Geographical Research examines how the COVID-19 pandemic has impacted international higher education and the mobility of students around the globe, noting that universities face the urgent task of reimagining alternative futures for themselves.

New research from Boston Medical Center identifies elevated mortality risk for women with back pain when compared to women without back pain. Back pain was not associated with mortality among men indicating long-term consequences of back pain may differ by sex.

As President Biden's $2 trillion American Jobs Plan places the nation's infrastructure in the spotlight, new research from the University of Georgia suggests states can save money and extend the life of their bridges by taking a fresh approach to how they prioritize maintenance.

Recent growth in the number of healthcare workers providing home care for Medicare patients is "small and inadequate" compared with the increasing demand in an aging America, a new study suggests.

Marketing can be used to benefit the world.

Researchers at Penn Medicine have identified more genetic mutations that strongly predispose younger, otherwise healthy women to peripartum cardiomyopathy (PPCM), a rare condition characterized by weakness of the heart muscle that begins sometime during the final month of pregnancy through five months after delivery. PPCM can cause severe heart failure and often leads to lifelong heart failure and even death.

Researchers from NUS Yong Loo Lin School of Medicine's Infectious Diseases Translational Research Programme have identified two new proteins that play a critical role in the ability of EV-A71 to invade the central nervous system. One of these proteins is a druggable target, which means that there are drugs available that target this protein and which could potentially be used to limit the neurological complications associated with this illness.